年轻供肾在20-50岁受者中较小年龄供肾生存获益更优:ERA-EDTA登记研究
结果显示年轻供肾的10年移植肾衰竭累积发生率更低,移植肾生存时间更长,衰竭风险显著降低。
要点
- 年轻供肾较年长供肾在20-50岁受者中10年移植肾衰竭风险降低40%-45%。
- 年轻供肾的10年平均移植肾生存时间延长1年(20-<35岁受者)或9个月(35-<50岁受者)。
- 供者年龄每增加1岁,20-<35岁受者10年死亡风险增加2%,35-<50岁受者增加1%。
核心结论
- 在20-50岁成人受者中,年轻 deceased 供肾(20-<50岁)较年长供肾(50-<70岁)具有生存获益。
主要发现
- 10年移植肾衰竭累积发生率在年轻供肾组:20-<35岁受者22.0%(95%CI 19.1-24.9),35-<50岁受者15.3%(95%CI 13.7-16.9);年长供肾组:20-<35岁受者36.7%(95%CI 31.9-41.5),35-<50岁受者29.2%(95%CI 25.1-33.2)。
- 10年随访时,年轻供肾较年长供肾平均移植肾生存时间延长1年(20-<35岁受者)或9个月(35-<50岁受者)。
- 年轻供肾的移植肾衰竭风险较年长供肾降低45%[20-<35岁受者aHR 0.55(95%CI 0.44-0.68)]和40%[35-<50岁受者aHR 0.60(95%CI 0.53-0.67)]。
- 供者年龄每增加1岁,10年死亡风险增加2%[20-<35岁受者aHR 1.02(95%CI 1.00-1.04)]或1%[35-<50岁受者aHR 1.01(95%CI 1.00-1.01)]。
临床怎么用
- 对于20-50岁成人肾移植候选者,在考虑接受 deceased 供肾时,年轻供肾可能提供更优的长期移植肾生存。
- 需结合供者年龄评估移植肾衰竭风险,年轻受者接受年长供肾时风险更高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Updated survival outcomes of young recipients receiving young or old deceased donor kidneys are required when considering accepting a deceased donor kidney. METHODS: We examined outcomes in 6448 European kidney allografts donated from younger (≥20-<50 years) and older (≥50-<70 years) deceased donors when transplanted into very young (≥20-<35 years) or young (≥35-<50 years) adult recipients. Outcomes of first kidney transplantations during 2000-13 and followed-up to 2015 were determined via competing risk, restricted mean survival and Cox regression methods. RESULTS: The 10-year cumulative incidence of graft failure was lowest in very young {22.0% [95% confidence interval (95% CI) 19.1-24.9]} and young [15.3% (95% CI 13.7-16.9)] recipients of younger donor kidneys and highest in very young [36.7% (95% CI 31.9-41.5)] and young [29.2% (95% CI 25.1-33.2)] recipients of older donor kidneys. At the 10-year follow-up, younger donor kidneys had a 1 year (very young) or 9 months (young) longer mean graft survival time compared with older donor kidneys. Graft failure risk in younger donor kidneys was 45% [very young adjusted hazard ratio (aHR) 0.55 (95% CI 0.44-0.68)] and 40% [young aHR 0.60 (95% CI 0.53-0.67)] lower compared with older donor kidneys. A 1-year increase in donor age resulted in a 2% [very young aHR 1.02 (95% CI 1.00-1.04)] or 1% [young aHR 1.01 (95% CI 1.00-1.01)] increase in the 10-year risk of death. CONCLUSIONS: Younger donor kidneys show survival benefits over older donor kidneys in adult recipients ages 20-50 years. Updated survival outcomes from older deceased donors are necessary due to advances in transplantation medicine and the increasing role these donors play in organ transplantation.
引用
- Pippias M, Jager KJ, Åsberg A, et al. Young deceased donor kidneys show a survival benefit over older donor kidneys in transplant recipients aged 20-50 years: a study by the ERA-EDTA Registry. Nephrol Dial Transplant. 2020. PMID: 30203080. doi:10.1093/ndt/gfy268
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。